论文部分内容阅读
目的评价经内镜逆行胰胆管造影(ERCP)结合增强CT扫描对胰腺癌的诊断价值。方法回顾性分析本院2006年10月至2009年10月收治的胰腺癌患者68例,其中33例行ERCP检查,68例行增强CT扫描检查,并与68例体表B超(B-US)检查结果对照。结果ERCP的诊断准确率为87.88%(29/33),增强CT扫描为88.24%(60/68),B-US为47.06%(32/68),ERCP结合增强CT扫描为96.97%(32/33)。ERCP诊断胰腺癌的准确率显著高于B-US,ERCP结合增强CT扫描诊断准确率明显高于单纯ERCP、增强CT扫描及B-US(均P<0.05)。结论ERCP在胰腺癌诊断中有重要价值,必要时结合增强CT扫描可以进一步提高诊断的准确性。
Objective To evaluate the value of endoscopic retrograde cholangiopancreatography (ERCP) combined with enhanced CT in the diagnosis of pancreatic cancer. Methods A retrospective analysis of 68 patients with pancreatic cancer admitted from October 2006 to October 2009 in our hospital was performed. Among them, 33 patients underwent ERCP and 68 underwent enhanced CT scan. Check the results of the control. Results The diagnostic accuracy rate of ERCP was 87.88% (29/33), enhanced CT scan was 88.24% (60/68), B-US was 47.06% (32/68), and ERCP combined enhanced CT scan was 96.97% (32 / 33). The accuracy of ERCP in diagnosing pancreatic cancer was significantly higher than that of B-US. The diagnostic accuracy of ERCP-enhanced CT scan was significantly higher than that of ERCP alone, enhanced CT scan and B-US (all P <0.05). Conclusions ERCP is of great value in the diagnosis of pancreatic cancer, if necessary, combined with enhanced CT scan can further improve the diagnostic accuracy.